BCH 222: Comprehensive Study Guide on Glycolysis and the Tricarboxylic Acid Cycle

Overview of Cellular Respiration and Core Pathways

Cellular respiration is the fundamental process by which biological cells generate adenosine triphosphate (ATPATP) through both oxidative (aerobic) and non-oxidative (anaerobic) pathways. This metabolic framework is composed of four primary components that work in sequence to extract energy from nutrients. The first stage is glycolysis, which occurs in the cytosol and involves anaerobic steps that break down glucose into pyruvate. The second stage is pyruvate oxidation, which serves as a bridge between glycolysis and the subsequent cycle by occurring in the mitochondrial matrix. The third stage is the Tricarboxylic Acid (TCATCA) cycle, a cyclic process that fully oxidizes acetyl-CoA to generate high-energy electron carriers. The final stage is the Electron Transport Chain (ETCETC), which utilizes the carriers NADHNADH and FADH2FADH_2 to drive the synthesis of ATPATP through oxidative phosphorylation.

Introduction and Overview of Glycolysis

Glycolysis is a ten-step biochemical process that converts one molecule of glucose, a 6-carbon sugar, into two molecules of pyruvate, which is a 3-carbon compound. This pathway takes place entirely within the cytosol of the cell and is categorized into two distinct phases. The first phase is the Energy Investment Phase (Steps 11 through 33), which utilizes ATPATP to modify glucose, effectively trapping it within the cell and preparing it for further reactions. The second phase is the Energy Payoff Phase (Steps 44 through 1010), where the cell generates ATPATP and NADHNADH through substrate-level phosphorylation and redox reactions.

The net result for every single molecule of glucose processed is the production of +2+2 net ATPATP (after subtracting the 22 ATPATP consumed during the investment phase), +2+2 NADHNADH, and 22 molecules of pyruvate. These products serve as fuel for further energy extraction. Depending on the availability of oxygen, these products enter either fermentation under anaerobic conditions or oxidative metabolism within the mitochondria under aerobic conditions.

Phase I: The Energy Investment Phase of Glycolysis

Step 11 involves the phosphorylation of glucose, catalyzed by the enzyme Hexokinase, or Glucokinase in liver cells. The reaction is Glucose+ATP→Glucose-6-Phosphate (G6P)+ADP\text{Glucose} + \text{ATP} \rightarrow \text{Glucose-6-Phosphate (G6P)} + \text{ADP}. This reaction is irreversible and serves the critical function of trapping glucose inside the cell. Hexokinase is highly active in most tissues and exhibits a low Michaelis constant (KmK_m), indicating a high affinity for glucose. In contrast, liver glucokinase has a higher KmK_m, which is suited for the liver’s role in regulating blood glucose levels. This step is regulated by feedback inhibition, where G6PG6P inhibits hexokinase to prevent excessive accumulation.

Step 22 is an isomerization reaction catalyzed by Phosphoglucose Isomerase, converting Glucose-6-Phosphate→Fructose-6-Phosphate\text{Glucose-6-Phosphate} \rightarrow \text{Fructose-6-Phosphate}. This step rearranges an aldose into a ketose. The reaction is reversible and provides a link to the pentose phosphate pathway, which supplies intermediates for nucleotide synthesis.

Step 33 is the commitment step involving the phosphorylation of fructose-6-phosphate by the enzyme Phosphofructokinase-1 (PFK−1PFK-1). The reaction is Fructose-6-Phosphate+ATP→Fructose-1,6-Bisphosphate+ADP\text{Fructose-6-Phosphate} + \text{ATP} \rightarrow \text{Fructose-1,6-Bisphosphate} + \text{ADP}. This is considered the rate-limiting step of glycolysis and commits the substrate to the pathway. Regulations of PFK−1PFK-1 include activators such as AMPAMP, signifying low-energy status, and fructose-2,6-bisphosphate, which is a powerful hormone-mediated activator. Inhibitors include ATPATP, signifying high energy, and citrate, which links glycolytic flux to the status of the TCATCA cycle.

Phase II: The Energy Payoff Phase of Glycolysis

Following the investment phase, the 6-carbon fructose-1,6-bisphosphate is cleaved into two 3-carbon molecules. Step 44 involves the enzyme Aldolase, which catalyzes the reaction Fructose-1,6-Bisphosphate→Glyceraldehyde-3-Phosphate (G3P)+Dihydroxyacetone Phosphate (DHAP)\text{Fructose-1,6-Bisphosphate} \rightarrow \text{Glyceraldehyde-3-Phosphate (G3P)} + \text{Dihydroxyacetone Phosphate (DHAP)}. Step 55 involves the Interconversion of DHAPDHAP and G3PG3P via the enzyme Triose Phosphate Isomerase (TPITPI). While both are formed in equimolar amounts, only G3PG3P continues directly in the pathway. TPITPI is an extremely efficient enzyme; rare deficiencies in this enzyme can lead to haemolytic anaemia.

Step 66 is an oxidation and phosphorylation reaction catalyzed by Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDHGAPDH). The reaction is G3P+NAD++Pi→1,3-Bisphosphoglycerate (1,3BPG)+NADH+H+\text{G3P} + \text{NAD}^+ + \text{P}_i \rightarrow \text{1,3-Bisphosphoglycerate (1,3BPG)} + \text{NADH} + \text{H}^+. This is a key redox reaction where NAD+NAD^+ is reduced to NADHNADH. The enzyme forms a thioester intermediate to couple oxidation with phosphorylation.

Step 77 involves the first generation of ATPATP via substrate-level phosphorylation, catalyzed by Phosphoglycerate Kinase. The reaction is 1,3-Bisphosphoglycerate+ADP→3-Phosphoglycerate+ATP\text{1,3-Bisphosphoglycerate} + \text{ADP} \rightarrow \text{3-Phosphoglycerate} + \text{ATP}. This step recovers one ATPATP molecule for each G3PG3P molecule processed.

Step 88 is a rearrangement catalyzed by Phosphoglycerate Mutase, where 3-Phosphoglycerate→2-Phosphoglycerate\text{3-Phosphoglycerate} \rightarrow \text{2-Phosphoglycerate}. This is an intramolecular phosphate shift that prepares the molecule for dehydration.

Step 99 is a dehydration reaction catalyzed by Enolase, converting 2-Phosphoglycerate→Phosphoenolpyruvate (PEP)+H2O\text{2-Phosphoglycerate} \rightarrow \text{Phosphoenolpyruvate (PEP)} + \text{H}_2\text{O}. The removal of water creates a high-energy enol phosphate bond. While reversible, the reaction is pulled forward by the subsequent ATPATP-generating step.

Step 1010 is the final ATPATP generation and formation of pyruvate, catalyzed by Pyruvate Kinase. The reaction is Phosphoenolpyruvate+ADP→Pyruvate+ATP\text{Phosphoenolpyruvate} + \text{ADP} \rightarrow \text{Pyruvate} + \text{ATP}. This yielded ATPATP accounts for the second of the two ATPATP molecules produced per PEPPEP. regulation includes feed-forward activation by fructose-1,6-bisphosphate and inhibition by ATPATP and acetyl-CoA.

Physiological Fates of Pyruvate

Pyruvate serves as a biochemical hub connecting carbohydrate, lipid, and amino acid metabolism. Its fate depends heavily on cellular oxygen availability and energy status. Under aerobic conditions, pyruvate enters the mitochondria where the Pyruvate Dehydrogenase (PDHPDH) complex converts it into Acetyl-CoA (Pyruvate+Coenzyme A+NAD+→Acetyl-CoA+CO2+NADH\text{Pyruvate} + \text{Coenzyme A} + \text{NAD}^+ \rightarrow \text{Acetyl-CoA} + \text{CO}_2 + \text{NADH}). Under anaerobic conditions, such as in skeletal muscle during intense exercise or in red blood cells, pyruvate is reduced to lactate by Lactate Dehydrogenase (LDHLDH) to regenerate NAD+NAD^+ for glycolysis.

The Cori Cycle describes the relationship where peripheral tissues produce lactate, which travels through the blood to the liver to be converted back into glucose at a cost of 66 ATPATP. In hepatic failure, this cycle stalls, leading to hyperlactatemia. Pyruvate can also be transaminated to Alanine via Alanine Aminotransferase (ALTALT). This allows muscle and peripheral tissues to send nitrogen groups to the liver, where alanine is reconverted to pyruvate for gluconeogenesis and nitrogen is processed into urea via the urea cycle. Clinical levels of ALT>ASTALT > AST often indicate viral hepatitis due to cytosolic ALTALT leakage.

Furthermore, pyruvate can be carboxylated to Oxaloacetate by the enzyme Pyruvate Carboxylase. This is a biotin-dependent reaction requiring ATPATP and HCO3−\text{HCO}_3^-. It is activated allosterically by Acetyl-CoA and serves two roles: anaplerosis (refilling the TCATCA cycle when intermediates are siphoned off for needs like haem synthesis) and as the first committed step of gluconeogenesis, leading to the formation of Phosphoenolpyruvate (PEPPEP) via Phosphoenolpyruvate Carboxykinase (PEPCKPEPCK). Minor fates of pyruvate include conversion to malate via the malic enzyme for NADPHNADPH production, conversion to oxalate (relevant in ethylene glycol poisoning), or conversion to acetoacetate in ketogenic amino acid catabolism.

The Pyruvate Dehydrogenase (PDH) Complex

The PDH complex catalyzes the oxidative decarboxylation of pyruvate to Acetyl-CoA. This complex requires five specific cofactors often remembered by the mnemonic "Tender Loving Care For Nantes": Thiamine-PP (B1B_1), Lipoate, Coenzyme A, FADFAD (B2B_2), and NAD+NAD^+ (B3B_3). The complex is regulated by PDH kinase, which inhibits the enzyme, and PDH phosphatase, which activates it. It is also subject to product inhibition by Acetyl-CoA and NADHNADH. Deficiencies in PDHPDH lead to early-infantile lactic acidosis and neurodegeneration. Treatment trials for these conditions include dichloroacetate (which inhibits the kinase), high-fat/low-carb diets, and thiamine loading.

Detailed Steps of the Tricarboxylic Acid (TCA) Cycle

The TCATCA cycle, also known as the Krebs cycle or citric acid cycle, takes place in the mitochondrial matrix. Its primary purpose is to fully oxidize acetyl-CoA derived from carbohydrates, fatty acids, or amino acids into carbon dioxide (CO2CO_2) while producing high-energy electron carriers. Per turn of the cycle (per Acetyl-CoA), the yield is 33 NADHNADH, 11 FADH2FADH_2, and 11 GTPGTP (or ATPATP). Since one glucose molecule produces two Acetyl-CoA molecules, these yields are doubled per glucose molecule.

Step 11 is Citrate Formation, catalyzed by Citrate Synthase. The reaction is Acetyl-CoA+Oxaloacetate+H2O→Citrate+CoA-SH\text{Acetyl-CoA} + \text{Oxaloacetate} + \text{H}_2\text{O} \rightarrow \text{Citrate} + \text{CoA-SH}. This irreversible, exergonic condensation commits acetyl-CoA to the cycle and is inhibited by high levels of ATPATP and NADHNADH.

Step 22 is Citrate Isomerization by Aconitase, producing Isocitrate via a reversible dehydration–rehydration mechanism with a cis-aconitate intermediate. Aconitase contains an iron-sulfur cluster that is sensitive to inactivation by oxidative stress.

Step 33 is the Oxidative Decarboxylation of Isocitrate, catalyzed by Isocitrate Dehydrogenase (IDHIDH). The reaction is \text{Isocitrate} + \text{NAD}^+ \rightarrow \text{̑-Ketoglutarate} + \text{NADH} + \text{CO}_2. This is the primary rate-limiting and regulatory step, activated by ADPADP and Ca2+Ca^{2+} and inhibited by ATPATP and NADHNADH.

Step 44 is the Oxidative Decarboxylation of ̑-Ketoglutarate, catalyzed by the ̑-Ketoglutarate Dehydrogenase Complex. The reaction is \text{̑-Ketoglutarate} + \text{NAD}^+ + \text{CoA-SH} \rightarrow \text{Succinyl-CoA} + \text{NADH} + \text{CO}_2. This multienzyme complex is similar to the PDHPDH complex and is inhibited by NADHNADH and its product, Succinyl-CoA.

Step 55 is Substrate-Level Phosphorylation by Succinyl-CoA Synthetase, which converts Succinyl-CoA+GDP (or ADP)+Pi→Succinate+CoA-SH+GTP (or ATP)\text{Succinyl-CoA} + \text{GDP (or ADP)} + \text{P}_i \rightarrow \text{Succinate} + \text{CoA-SH} + \text{GTP (or ATP)}. The high-energy thioester bond of Succinyl-CoA drives the reaction.

Step 66 is Succinate Oxidation by Succinate Dehydrogenase. The reaction is Succinate+FAD→Fumarate+FADH2\text{Succinate} + \text{FAD} \rightarrow \text{Fumarate} + \text{FADH}_2. This enzyme is unique because it is embedded in the inner mitochondrial membrane and serves as Complex II of the Electron Transport Chain.

Step 77 is the Hydration of Fumarate by Fumarase (Fumarate Hydratase) to produce Malate (Fumarate+H2O→Malate\text{Fumarate} + \text{H}_2\text{O} \rightarrow \text{Malate}).

Step 88 is the Regeneration of Oxaloacetate by Malate Dehydrogenase (Malate+NAD+→Oxaloacetate+NADH+H+\text{Malate} + \text{NAD}^+ \rightarrow \text{Oxaloacetate} + \text{NADH} + \text{H}^+). While endergonic under standard conditions, it is driven forward in vivo by the constant removal of oxaloacetate by citrate synthase.

Clinical Correlates and Metabolic Dysregulation

Enzyme deficiencies in glycolysis lead to specific clinical presentations. Phosphofructokinase-1 deficiency, known as Tarui disease, manifests as exercise intolerance, muscle cramps, and haemolytic anaemia. Triose Phosphate Isomerase (TPITPI) deficiency is rare but leads to severe haemolytic anaemia and neurological dysfunction. In cancer metabolism, many cells exhibit the Warburg Effect, where they prefer glycolysis for ATPATP production even in the presence of oxygen, resulting in high rates of glucose uptake and lactate production. This is often visualized on PET scans as "hot spots."

TCATCA cycle and pyruvate handling disorders also have significant clinical impact. Pyruvate Dehydrogenase deficiency results in pyruvate accumulation, lactic acidosis, and developmental delays. Mutations in Isocitrate Dehydrogenase (IDH1IDH1 and IDH2IDH2) are linked to gliomas and acute myeloid leukaemia because they produce the oncometabolite 2-hydroxyglutarate. Succinate Dehydrogenase mutations are associated with paragangliomas and pheochromocytomas; the accumulation of succinate inhibits prolyl hydroxylases and stabilizes hypoxia-inducible factors (HIFsHIFs).

In instances of sepsis or shock, serum lactate levels exceeding 4 mmol/L4 \text{ mmol/L} indicate a physiological red flag for mesenteric ischemia or metformin toxicity. Metabolic adaptations during hypoxia also increase reliance on glycolysis, where lactate accumulation contributes to muscle fatigue.

Questions & Discussion

Case Study: Metabolic and Vitamin Analysis An 18-month-old boy presents with hypotonia, a serum lactate level of 10 mmol/L10 \text{ mmol/L}, and normal blood glucose. MRI imaging reveals lesions in the basal ganglia. Based on these symptoms, which vitamin trial is most warranted?

The symptoms, specifically the high lactate and basal ganglia lesions (indicative of Leigh-like syndrome), strongly suggest a deficiency in the Pyruvate Dehydrogenase complex. Therefore, a trial of Vitamin B1B_1 (Thiamine), which is a critical cofactor for both the PDHPDH and ̑-ketoglutarate dehydrogenase complexes, is the appropriate intervention.

Diagnostic Laboratory Panels The lactate/pyruvate ratio is a critical diagnostic tool. A ratio greater than 2525 suggests a respiratory chain block in the mitochondria. A ratio less than 1010 suggests a deficiency in the Pyruvate Dehydrogenase complex. Additionally, the ALT/ASTALT/AST ratio provides clues to alanine trafficking and liver health. Congenital lactic acidaemias may be investigated via CSF pyruvate levels, while urine organic acids are checked for evidence of D-lactate encephalopathy, which can occur in short-bowel syndrome.

Therapeutic Interventions Several medications target these pathways. Dichloroacetate activates PDH phosphatase and is used in trials for PDHPDH deficiency and MELAS. Thiamine loading is used for cofactor replacement in cases of alcoholism, refeeding syndrome, or as a malaria treatment adjunct. Biotin is a required cofactor for Pyruvate Carboxylase in cases of inborn errors or long-term valproate use. Metformin is contra-indicated when eGFR<30eGFR < 30 or in septic shock because it can decrease oxidative phosphorylation and increase lactate. Experimental pyruvate infusions are being researched as an antioxidant and H+H^+ buffer for resuscitation.